MAPT and amyloidosis: Four of these studies assessed both amyloid and tau levels in cerebrospinal fluid (CSF) (total tau and p-tau in three (30, 73, 92); p-tau in one (33)), of which one also conducted brain magnetic resonance imaging (MRI) (92).